Biocatalysts is celebrating its 35th birthday this year with a £6+ million investment in an 11,000 sq ft extension to the existing building which has just been completed.
Speciality enzyme company Biocatalysts is celebrating its 35th birthday this year with a major investment into its future manufacturing capacity.
Over £6 million will be invested in total, comprising an 11,000 sq ft extension to the existing building which has just been completed. The next step is to fit out the building, including a 10 cubic metre fermenter and down-stream processing machinery. It will be controlled by what the company describes as state of the art software to maximise capacity and enhance efficiencies. The new production area also offers future expansion capacity, negating the need for the company to move.
As well as the increased manufacturing capacity, Biocatalysts recently launched MetXtra, which it describes as a unique enzyme discovery platform that provides a fast and cost-effective approach to novel enzyme development.
Daren Bryce, Commercial Director at Biocatalysts, said: “This represents a very exciting time in the speciality enzyme field. The unique breadth of offering, from discovery right through to large scale production, that Biocatalysts has to offer will allow previously in-accessible novel enzymes at commercial scale to our customers.”